224 related articles for article (PubMed ID: 28891266)
1. Analysis of outcomes achieved with squamous cell carcinomas of the anus in a single university hospital over the last two decades: Clinical response rate, relapse and survival of 190 patients.
Gravante G; Stephenson JA; Elshaer M; Osman A; Vasanthan S; Mullineux JH; Gani MAD; Sharpe D; Yeung J; Norwood M; Miller A; Boyle K; Hemingway D
J Surg Oncol; 2018 Feb; 117(2):269-274. PubMed ID: 28891266
[TBL] [Abstract][Full Text] [Related]
2. Concomitant chemoradiotherapy with Cisplatin plus 5-Fluorouracil for anal squamous cell carcinoma.
El-Hadaad HA; Wahba HA; Roshdy S
J Gastrointest Cancer; 2015 Jun; 46(2):156-60. PubMed ID: 25810165
[TBL] [Abstract][Full Text] [Related]
3. Salvage surgery for residual primary and locally recurrent anal squamous cell carcinoma after chemoradiotherapy in HIV-positive individuals.
Cunin L; Alfa-Wali M; Turner J; Bower M; Ion L; Allen-Mersh T
Ann Surg Oncol; 2014 Feb; 21(2):527-32. PubMed ID: 24242676
[TBL] [Abstract][Full Text] [Related]
4. Survival following salvage abdominoperineal resection for persistent and recurrent squamous cell carcinoma of the anus: do these disease categories affect survival?
Severino NP; Chadi SA; Rosen L; Coiro S; Choman E; Berho M; Wexner SD
Colorectal Dis; 2016 Oct; 18(10):959-966. PubMed ID: 26850085
[TBL] [Abstract][Full Text] [Related]
5. Chemoradiotherapy for squamous cell anal carcinoma: a review of prognostic factors.
Kapacee ZA; Susnerwala S; Wise M; Biswas A; Danwata F; Scott N
Colorectal Dis; 2016 Nov; 18(11):1080-1086. PubMed ID: 27028038
[TBL] [Abstract][Full Text] [Related]
6. Chemoradiotherapy of anal carcinoma: survival and recurrence in an unselected national cohort.
Bentzen AG; Guren MG; Wanderås EH; Frykholm G; Tveit KM; Wilsgaard T; Dahl O; Balteskard L
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e173-80. PubMed ID: 22436791
[TBL] [Abstract][Full Text] [Related]
7. Recurrent squamous cell carcinoma of the anal canal. Predictors of initial treatment failure and results of salvage therapy.
Longo WE; Vernava AM; Wade TP; Coplin MA; Virgo KS; Johnson FE
Ann Surg; 1994 Jul; 220(1):40-9. PubMed ID: 8024357
[TBL] [Abstract][Full Text] [Related]
8. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes.
Klas JV; Rothenberger DA; Wong WD; Madoff RD
Cancer; 1999 Apr; 85(8):1686-93. PubMed ID: 10223561
[TBL] [Abstract][Full Text] [Related]
9. Phase II Study of Capecitabine in Substitution of 5-FU in the Chemoradiotherapy Regimen for Patients with Localized Squamous Cell Carcinoma of the Anal Canal.
Oliveira SC; Moniz CM; Riechelmann R; Alex AK; Braghirolli MI; Bariani G; Nahas C; Hoff PM
J Gastrointest Cancer; 2016 Mar; 47(1):75-81. PubMed ID: 26691173
[TBL] [Abstract][Full Text] [Related]
10. Multimodality therapy including salvage surgical resection and intraoperative radiotherapy for patients with squamous-cell carcinoma of the anus with residual or recurrent disease after primary chemoradiotherapy.
Hallemeier CL; You YN; Larson DW; Dozois EJ; Nelson H; Klein KA; Miller RC; Haddock MG
Dis Colon Rectum; 2014 Apr; 57(4):442-8. PubMed ID: 24608300
[TBL] [Abstract][Full Text] [Related]
11. Salvage Abdominoperineal Resection for Squamous Cell Anal Cancer: A 30-Year Single-Institution Experience.
Hagemans JAW; Blinde SE; Nuyttens JJ; Morshuis WG; Mureau MAM; Rothbarth J; Verhoef C; Burger JWA
Ann Surg Oncol; 2018 Jul; 25(7):1970-1979. PubMed ID: 29691737
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of salvage surgery for squamous cell carcinoma of the anal canal.
Schiller DE; Cummings BJ; Rai S; Le LW; Last L; Davey P; Easson A; Smith AJ; Swallow CJ
Ann Surg Oncol; 2007 Oct; 14(10):2780-9. PubMed ID: 17638059
[TBL] [Abstract][Full Text] [Related]
13. Anus-preservation treatment for anal cancer: retrospective analysis at a single institution.
Chen YW; Yen SH; Chen SY; Huang PI; Shiau CY; Liu YM; Lin JK; Wang LW
J Surg Oncol; 2007 Oct; 96(5):374-80. PubMed ID: 17492635
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal.
Eng C; Chang GJ; You YN; Das P; Xing Y; Delclos M; Wolff RA; Rodriguez-Bigas MA; Skibber J; Ohinata A; Gould S; Phillips J; Crane CH
Cancer; 2013 Nov; 119(21):3769-75. PubMed ID: 24037775
[TBL] [Abstract][Full Text] [Related]
15. Salvage Surgery for Locoregional Failure in Anal Squamous Cell Carcinoma.
Guerra GR; Kong JC; Bernardi MP; Ramsay RG; Phillips WA; Warrier SK; Lynch AC; Ngan SY; Heriot AG
Dis Colon Rectum; 2018 Feb; 61(2):179-186. PubMed ID: 29337772
[TBL] [Abstract][Full Text] [Related]
16. Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial.
Glynne-Jones R; Sebag-Montefiore D; Meadows HM; Cunningham D; Begum R; Adab F; Benstead K; Harte RJ; Stewart J; Beare S; Hackshaw A; Kadalayil L;
Lancet Oncol; 2017 Mar; 18(3):347-356. PubMed ID: 28209296
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive treatment experience of anal squamous cell carcinoma from a tertiary cancer center in South China.
Yuan Y; Xie WH; Li RZ; Chang H; Zeng ZF; Gao YH; Wang QX; Xiao WW
Cancer Med; 2022 Jan; 11(1):117-127. PubMed ID: 34816622
[TBL] [Abstract][Full Text] [Related]
18. Twenty-five-year experience with radical chemoradiation for anal cancer.
Tomaszewski JM; Link E; Leong T; Heriot A; Vazquez M; Chander S; Chu J; Foo M; Lee MT; Lynch CA; Mackay J; Michael M; Tran P; Ngan SY
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):552-8. PubMed ID: 22019078
[TBL] [Abstract][Full Text] [Related]
19. EMR as salvage treatment for patients with locoregional failure of definitive chemoradiotherapy for esophageal cancer.
Hattori S; Muto M; Ohtsu A; Boku N; Manabe T; Doi T; Ishikura S; Yoshida S
Gastrointest Endosc; 2003 Jul; 58(1):65-70. PubMed ID: 12838223
[TBL] [Abstract][Full Text] [Related]
20. The assessment of local response using magnetic resonance imaging at 3- and 6-month post chemoradiotherapy in patients with anal cancer.
Kochhar R; Renehan AG; Mullan D; Chakrabarty B; Saunders MP; Carrington BM
Eur Radiol; 2017 Feb; 27(2):607-617. PubMed ID: 27090113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
